Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Chelator   Deferoxamine mesylate  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Deferoxamina Spain
Deferoxamine mesylate Canada, United States of America
Deferoxaminmesilat Germany
Desferal Argentina, Australia, Austria, Belgium, Canada, Chile, Colombia, Denmark, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, India, Iran, Ireland, Italy, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, Norway, Poland, Portugal, Romania, Saudi Arabia, Sweden, Switzerland, Tunisia, Turkey, United States of America, Venezuela
Desferin Denmark, Spain
Desferioxamine mesilate Great Britain
Desfonak Iran
PMS desferoxamine Canada
Talifer Mexico
Stability in solutions   injection   Stability in solutions : Deferoxamine mesylate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 100 mg/ml 25°C Not specified
24 Hour
3671
Manufacturer's stability data
Polyvinyl chloride Water for Injection 210 mg/ml 20°C-23°C Light
21 Day
1669
Level of evidence C
Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 25°C Not specified
7 Day
2156
Level of evidence D
Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 37°C Not specified
48 Hour
2156
Level of evidence D
Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,35 mg/ml 4°C Not specified
15 Day
2156
Level of evidence D
Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,35 mg/ml 25°C Not specified
7 Day
2156
Level of evidence D
Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,35 mg/ml 37°C Not specified
48 Hour
2156
Level of evidence D
Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,35 mg/ml 4°C Not specified
15 Day
2156
Level of evidence D
Polypropylen Syringe Water for Injection 250 mg/ml 30°C Not specified
14 Day
5
Level of evidence B
Polyisoprene elastomer NaCl 0,9% or Glucose 5% 5 mg/ml 25°C Not specified
12 Day
604
Manufacturer's stability data
Not specified Sodium chloride 0,9% ? mg/ml 25°C Not specified
24 Hour
3671
Manufacturer's stability data
Not specified Glucose 5% ? mg/ml 25°C Not specified
36 Hour
3671
Manufacturer's stability data
Not specified Ringer’s lactate solution ? mg/ml 25°C Not specified
24 Hour
3671
Manufacturer's stability data
  Mentions Légales